Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA expands approval of breast cancer drug Kisqali
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients: Weighing The Risks & Benefits of Kisqali
The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence.
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery.
Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR-positive,
pharmaphorum
2d
Lilly on alert as new Kisqali approval threatens Verzenio
Verzenio was approved for a similar adjuvant indication last year, having been used for a couple of years only in patients ...
Targeted Oncology
2d
Ribociclib-Based Therapy Extends Survival in HR+/HER2– Breast Cancer
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
Boy kills bear, saves father
Secret Service probing post
Body found in SUV
$230 million crypto theft
Russia threatens retaliation
Feds subpoena Schaeffer
Hold campaign event in MI
Hiker injured in bear attack
Drug price challenge revived
WI high court to decide
Whooping cough cases spike
House repeals emission rules
FDA approves flu vaccine
SC 1st execution in 13 years
Hand count approved in GA
1st rabies outbreak in seals
Pandas leaving for China
144K+ Mavericks recalled
Jurors begin deliberations
Sues pharmacy middlemen
Recalling 449K+ vehicles
Bill to boost security OK'd
Stein's ballot bid rejected
Top Hezbollah leader killed?
MS sheriff's office probe
Baby powder recalled
Raises settlement offer
In-person voting begins
PGA welcomes LIV players
Disney to stop using Slack
Related topics
Food and Drug Administration
Breast cancer
Feedback